Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies

Evaluation of the Safety and Immunogenicity of Autologous Thrombosomes® in Healthy Human Subjects; A Microdose Escalation Study (Cohorts 1 - 4) and Repeat Microdose Immunogenicity Study (Cohort 5)

NCT02223117 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

NCT02158936 ·Status: TERMINATED ·Phase: PHASE3

Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)

NCT06594146 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy

NCT00102323 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)

NCT00472290 ·Status: COMPLETED ·Phase: NA

Anagrelide Retard in Essential Thrombocythemia

NCT02076815 ·Status: COMPLETED ·Phase: PHASE3

Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness

NCT06792019 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Dual Vaccine Trial in Myeloproliferative Neoplasms

NCT04051307 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients

NCT02614846 ·Status: UNKNOWN ·Phase: PHASE1

Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training

NCT02085993 ·Status: COMPLETED

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia

NCT02227693 ·Status: COMPLETED ·Phase: PHASE2

Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003)

NCT04254978 ·Status: COMPLETED ·Phase: PHASE2

A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

NCT02323178 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia

NCT01230775 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Study of Monoclonal Antibody TB-402 in Healthy Male Volunteers

NCT00612196 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP

NCT03102593 ·Status: COMPLETED ·Phase: PHASE2

Eltrombopag Phase III Study In Chinese Chronic ITP Patients

NCT01762761 ·Status: COMPLETED ·Phase: PHASE3

Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

NCT00117143 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

NCT02279173 ·Status: COMPLETED ·Phase: PHASE3

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

NCT00359463 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)

NCT04021173 ·Status: UNKNOWN ·Phase: PHASE2

A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects

NCT05088642 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device

NCT01210716 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

NCT00111475 ·Status: COMPLETED ·Phase: PHASE2

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia

NCT05995054 ·Status: RECRUITING ·Phase: PHASE2